BioArctic AB (publ) (BIOA-B) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.021x

Based on the latest financial reports, BioArctic AB (publ) (BIOA-B) has a cash flow conversion efficiency ratio of -0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-41.19 Million ≈ $-4.43 Million USD) by net assets (Skr1.97 Billion ≈ $211.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BioArctic AB (publ) defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

BioArctic AB (publ) - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how BioArctic AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

BioArctic AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioArctic AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Compagnie Financiere Tradition SW:CFT	0.099x
Grupo Bafar S.A.B. de C.V MX:BAFARB	0.056x
Sanhe Tongfei Refrigeration Co. Ltd. SHE:300990	0.029x
Elite Advanced Laser Corp TW:3450	0.073x
Freshworks Inc NASDAQ:FRSH	0.069x
Netcompany Group A/S CO:NETC	0.024x
CIMC Enric Holdings Limited F:E8F	0.021x
Blue Bird Corp NASDAQ:BLBD	0.160x

Annual Cash Flow Conversion Efficiency for BioArctic AB (publ) (2015–2024)

The table below shows the annual cash flow conversion efficiency of BioArctic AB (publ) from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see BIOA-B market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr894.94 Million ≈ $96.31 Million	Skr-316.33 Million ≈ $-34.04 Million	-0.353x	-219.45%
2023-12-31	Skr1.05 Billion ≈ $112.63 Million	Skr309.69 Million ≈ $33.33 Million	0.296x	+835.38%
2022-12-31	Skr786.24 Million ≈ $84.61 Million	Skr-31.64 Million ≈ $-3.40 Million	-0.040x	+77.41%
2021-12-31	Skr788.68 Million ≈ $84.87 Million	Skr-140.46 Million ≈ $-15.12 Million	-0.178x	-74.98%
2020-12-31	Skr907.30 Million ≈ $97.64 Million	Skr-92.34 Million ≈ $-9.94 Million	-0.102x	-130.32%
2019-12-31	Skr974.50 Million ≈ $104.87 Million	Skr327.17 Million ≈ $35.21 Million	0.336x	+270.79%
2018-12-31	Skr1.02 Billion ≈ $109.52 Million	Skr-200.06 Million ≈ $-21.53 Million	-0.197x	+7.60%
2017-12-31	Skr636.13 Million ≈ $68.46 Million	Skr-135.33 Million ≈ $-14.56 Million	-0.213x	-101.91%
2016-12-31	Skr60.76 Million ≈ $6.54 Million	Skr675.13 Million ≈ $72.65 Million	11.111x	+7421.42%
2015-12-31	Skr108.28 Million ≈ $11.65 Million	Skr-16.43 Million ≈ $-1.77 Million	-0.152x	--

About BioArctic AB (publ)

ST:BIOA-B Sweden Biotechnology

Market Cap

$2.29 Billion

Skr21.23 Billion SEK

Market Cap Rank

#5896 Global

#80 in Sweden

Share Price

Skr286.00

Change (1 day)

-3.31%

52-Week Range

Skr175.90 - Skr364.40

All Time High

Skr377.80